Unknown

Dataset Information

0

Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects.


ABSTRACT: Each year, 33% of US citizens suffer from a musculoskeletal condition that requires medical intervention, with direct medical costs approaching $1 trillion USD per year. Despite the ubiquity of skeletal dysfunction, there are currently limited safe and efficacious bone growth factors in clinical use. Notch is a cell-cell communication pathway that regulates self-renewal and differentiation within the mesenchymal/osteoblast lineage. The principal Notch ligand in bone, Jagged-1, is a potent osteoinductive protein that positively regulates post-traumatic bone healing in animals. This report describes the temporal regulation of Notch during intramembranous bone formation using marrow ablation as a model system and demonstrates decreased bone formation following disruption of Jagged-1 in mesenchymal progenitor cells. Notch gain-of-function using recombinant Jagged-1 protein on collagen scaffolds promotes healing of craniofacial (calvarial) and appendicular (femoral) surgical defects in both mice and rats. Localized delivery of Jagged-1 promotes bone apposition and defect healing, while avoiding the diffuse bone hypertrophy characteristic of the clinically problematic bone morphogenetic proteins. It is concluded that Jagged-1 is a bone-anabolic agent with therapeutic potential for regenerating traumatic or congenital bone defects.

SUBMITTER: Youngstrom DW 

PROVIDER: S-EPMC5732299 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects.

Youngstrom Daniel W DW   Senos Rafael R   Zondervan Robert L RL   Brodeur Jack D JD   Lints Austin R AR   Young Devin R DR   Mitchell Troy L TL   Moore Megan E ME   Myers Marc H MH   Tseng Wei-Ju WJ   Loomes Kathleen M KM   Hankenson Kurt D KD  

NPJ Regenerative medicine 20171215


Each year, 33% of US citizens suffer from a musculoskeletal condition that requires medical intervention, with direct medical costs approaching $1 trillion USD per year. Despite the ubiquity of skeletal dysfunction, there are currently limited safe and efficacious bone growth factors in clinical use. Notch is a cell-cell communication pathway that regulates self-renewal and differentiation within the mesenchymal/osteoblast lineage. The principal Notch ligand in bone, Jagged-1, is a potent osteoi  ...[more]

Similar Datasets

| S-EPMC6524983 | biostudies-literature
| S-EPMC5459593 | biostudies-literature
| S-EPMC3591638 | biostudies-literature
| S-EPMC5177771 | biostudies-literature
| S-EPMC4903910 | biostudies-literature
| S-EPMC4466207 | biostudies-literature
| S-EPMC1769555 | biostudies-literature
| S-EPMC2719415 | biostudies-literature
| S-EPMC7846796 | biostudies-literature
| S-EPMC4414222 | biostudies-literature